ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2021 American Transplant Congress

    Trends of Kidney Transplant Volume During Covid-19 Era

    G. Rajashekar1, S. Chang1, K. Lentine2, J. Wellen1, T. Alhamad1, M. Merzkani1, H. Murad1

    1Nephrology, Washington University in St. Louis, Saint louis, MO, 2Nephrology, SSM Saint Louis University, Saint louis, MO

    *Purpose: The emergence of SARS-CoV-2 and the clinical syndrome of COVID-19 have significantly disrupted routine healthcare and life-saving procedures, including solid organ transplantation. This resulted…
  • 2021 American Transplant Congress

    Kidney Transplantation in Patients with Prior Coronavirus Disease 2019 (COVID-19)

    A. Santeusanio, A. Bhansali, M. Rana, S. Lerner, D. Von Ahrens, O. Sulimani, S. Farouk, F. Tedla, R. Shapiro

    Mount Sinai Hospital, New York, NY

    *Purpose: We describe short-term outcomes as well as peri- and post-transplant complications in patients with prior coronavirus disease 2019 (COVID-19) who subsequently underwent kidney transplantation.*Methods:…
  • 2021 American Transplant Congress

    Use of Immune Checkpoint Inhibitors in Solid Organ Transplant Recipients: A Scoping Review

    A. G. Anderson, M. Eubank, K. Murray

    University of Missouri, Columbia, MO

    *Purpose: Immune checkpoint inhibitors (ICI) are an emerging treatment for numerous advanced diseases, but their safety and efficacy in immunosuppressed transplant patients is not known.…
  • 2021 American Transplant Congress

    Racial/ethnic and Sex Disparities in Renal Transplant Waitlisting Accounting for Pre-Waitlist Mortality

    R. Hamoda1, R. Patzer2, M. Saunders1

    1University of Chicago, Chicago, IL, 2Emory University, Atlanta, GA

    *Purpose: The purpose of this study was to assess racial/ethnic and sex differences in access to the renal transplant deceased donor waiting list among incident…
  • 2021 American Transplant Congress

    Given the Potential Impact on Liver Transplant Selection, Revisiting the Current Standard of Diagnosis of Hepatocellular Carcinoma

    K. Amarell, B. Fisher, B. Park, K. Ko, B. Kallakury

    Department of Pathology & Laboratory Medicine, Georgetown University School of Medicine, Washington, DC

    *Purpose: The current standard of diagnosis of hepatocellular carcinoma (HCC) relies on non-invasive radiographic methods, namely computerized tomography (CT) and/or magnetic resonance imaging (MRI). However,…
  • 2021 American Transplant Congress

    Elevated Tacrolimus Levels in Hospitalized Organ Transplant Recipients with COVID-19

    K. Mecadon1, A. Hardesty2, K. Vieira3, R. Rogers3, B. Merhi4, A. J. Osband5, G. Bayliss4, R. Gohh4, P. Morrissey5, D. Farmakiotis3

    1Department of Pharmacy, Rhode Island Hospital, Providence, RI, 2Department of Internal Medicine, Residency, Warren Alpert Medical School of Brown University, Providence, RI, 3Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, 4Division of Nephrology, Warren Alpert Medical School of Brown University, Providence, RI, 5Department of Surgery (Transplantation), Warren Alpert Medical School of Brown University, Providence, RI

    *Purpose: The effect of COVID-19 on immunosuppressant drug levels in organ transplant recipients (OTRs) has not been adequately studied.*Methods: We retrospectively studied hospitalized adult (>18-year-old)…
  • 2021 American Transplant Congress

    High Levels of Sars-cov-2 Detected in Immunosuppressed Covid-19 Patient Environments Weeks Following Initial Positive Test

    C. E. Kuschner1, Z. Brune2, L. B. Becker1, L. Teperman1

    1North Shore University Hospital, Manhasset, NY, 2Feinstein Institutes for Medical Research, Manhasset, NY

    *Purpose: COVID-19 is a novel viral illness associated with significantly worse mortality, prolonged disease course, and extended periods of viral shedding in transplant patients on…
  • 2021 American Transplant Congress

    Donor-specific Anti-HLA Alloantibody in Kidney Transplant Recipients with COVID-19 Exhibit a Different Immunoglobulin Class and Subclass Profile When Compared to Anti-SARS-CoV-2 Antibodies

    A. Girnita1, L. Wang1, M. Fernandez-Vina1, E. Woodle2, P. Ahearn1, T. Yalamarti1, M. Menon3, Y. Azzi4, M. Melcher1, R. Bray5, H. Gebel5, E. Akalin4, P. Cravedi3, J. S. Maltzman1

    1Stanford University, Palo Alto, CA, 2University of Cincinnati, Cincinnati, OH, 3Icahn School of Medicine, NYC, NY, 4Einstein School of Medicine, NYC, NY, 5Emory University, Atlanta, GA

    *Purpose: Both anti-HLA and anti-SARS-CoV-2 antibodies target protein antigens. The aim of the present study was to compare the class and subclass profile of such…
  • 2021 American Transplant Congress

    Can an Organ Survive for More Than 100 Years Between Donor and Recipient

    R. Gruessner, J. Renz, A. C. Gruessner

    SUNY Downstate Medical Center, Brooklyn, NY

    *Purpose: It has been hypothesized that parenchymal grafts have a longer life expectancy than the cardio-cerebro-vascular system. We investigated the occurrence of deceased-donor liver (DDOLT),…
  • 2021 American Transplant Congress

    Excellent Pathological Response with Gemcitabine-based Protocol in Patient with Hilar Cholangiocarcinoma

    A. Saharia1, R. McMillan1, S. Kodali1, M. Javley2, C. M. Mobley1, M. J. Hobeika1, A. Shetty1, D. W. Victor1, R. McFadden1, M. Abdelrahim1, K. Heyne1, A. O. Gaber1, R. M. Ghobrial1

    1Houston Methodist Hospital, Houston, TX, 2MD Anderson Cancer Center, Houston, TX

    *Purpose: The standard treatment for hilar cholangiocarcinoma is using 5FU along with brachytherapy and external beam radiation. The downside of this regimen is the uncertain…
  • « Previous Page
  • 1
  • …
  • 212
  • 213
  • 214
  • 215
  • 216
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences